Corrigendum: 7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir

Angewandte Chemie - International Edition - United Kingdom
doi 10.1002/anie.201809594
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Berichtigung: 7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir

Angewandte Chemie
2018English

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

Clinical Pharmacokinetics
Pharmacology
2013English

Approaches to the Synthesis of a Novel, Anti-Hiv Active Integrase Inhibitor

Organic and Biomolecular Chemistry
Organic ChemistryTheoretical ChemistryBiochemistryPhysical
2013English

Synthesis and Anti-Hiv Activity of Some [Nucleoside Reverse Transcriptase Inhibitor]-C5′-Linker-[Integrase Inhibitor] Heterodimers as Inhibitors of HIV Replication

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2004English

Reply to Das and Berkhout, “How Polypurine Tract Changes in the HIV-1 RNA Genome Can Cause Resistance Against the Integrase Inhibitor Dolutegravir”

mBio
VirologyMicrobiology
2018English

Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients With Nucleoside Reverse Transcriptase Inhibitor Resistance

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2018English

Relationship Between HIV Integrase Polymorphisms and Integrase Inhibitor Susceptibility: An in Silico Analysis

Heliyon
Multidisciplinary
2018English

Prevalence of HIV-1 Integrase Mutations Related to Resistance to Dolutegravir in Raltegravir Naïve and Pretreated Patients

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Clinical Effectiveness of Dolutegravir in the Treatment of HIV/AIDS

Infection and Drug Resistance
Infectious DiseasesPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy